Twist Bioscience (TWST) Receives a Hold from SVB Securities

SVB Securities analyst Puneet Souda maintained a Hold rating on Twist Bioscience (TWSTResearch Report) on July 18. The company’s shares closed last Tuesday at $43.46, close to its 52-week low of $25.07.

According to TipRanks.com, Souda is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -11.0% and a 35.2% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Myriad Genetics.

Twist Bioscience has an analyst consensus of Moderate Buy, with a price target consensus of $38.25.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $139.99 and a one-year low of $25.07. Currently, Twist Bioscience has an average volume of 1.25M.

Based on the recent corporate insider activity of 172 insiders, corporate insider sentiment is neutral on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.

Read More on TWST:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More